EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer

Yuri Kim, Seong Won Kim, David Saul, Meraj Neyazi, Manuel Schmid, Hiroko Wakimoto, Neil Slaven, Joshua H Lee, Olivia Layton, Lauren K Wasson, Justin H Letendre, Feng Xiao und 20 weitere

Journal of Clinical Investigation · 17.02.2025 · 135 (4)

DOI: 10.1172/jci183353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.12.2024. Verfasst von Yuri Kim und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Connectin, Sarcomeres, Introns, Myocytes, Cardiac. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous truncating variants in the sarcomere protein titin (TTN) are the most common genetic cause of heart failure. To understand mechanisms that regulate abundant cardiomyocyte (CM) TTN expression, we characterized highly conserved intron 1 sequences that exhibited dynamic changes in chromatin accessibility during differentiation of human CMs from induced pluripotent stem cells (hiPSC-CMs). Homozygous deletion of these sequences in mice caused embryonic lethality, whereas heterozygous mice showed an allele-specific reduction in Ttn expression. A 296 bp fragment of this element, denoted E1, was sufficient to drive expression of a reporter gene in hiPSC-CMs. Deletion of E1 downregulated TTN expression, impaired sarcomerogenesis, and decreased contractility in hiPSC-CMs. Site-directed mutagenesis of predicted binding sites of NK2 homeobox 5 (NKX2-5) and myocyte enhancer factor 2 (MEF2) within E1 abolished its transcriptional activity. In embryonic mice expressing E1 reporter gene constructs, we validated in vivo cardiac-specific activity of E1 and the requirement for NKX2-5– and MEF2-binding sequences. Moreover, isogenic hiPSC-CMs containing a rare E1 variant in the predicted MEF2-binding motif that was identified in a patient with unexplained dilated cardiomyopathy (DCM) showed reduced TTN expression. Together, these discoveries define an essential, functional enhancer that regulates TTN expression. Manipulation of this element may advance therapeutic strategies to treat DCM caused by TTN haploinsufficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConnectinSarcomeresIntronsMyocytes, CardiacEnhancer Elements, GeneticAnimalsHumansMiceInduced Pluripotent Stem CellsHomeobox Protein Nkx-2.5MEF2 Transcription FactorsCell DifferentiationProtein Kinases

Stichwörter der Autor:innen

CardiologyCardiovascular diseaseGenetic diseasesGeneticsHeart failure

Substanzen

ConnectinHomeobox Protein Nkx-2.5TTN protein, humanMEF2 Transcription Factorstitin protein, mouseNKX2-5 protein, humanNkx2-5 protein, mouseProtein Kinases

Autor:innen und Institutionen

  • Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Heart Center, Technical University of Munich, Munich, Germany.
  • Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
  • Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.

Förderung

  • NICHD NIH HHS
  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • NHLBI Division of Intramural Research
  • National Institute of Child Health and Human Development
  • National Human Genome Research Institute
  • National Science Foundation
  • Howard Hughes Medical Institute

Zitieren

APA

Kim, Y., Kim, S. W., Saul, D., Neyazi, M., Schmid, M., Wakimoto, H., Slaven, N., Lee, J. H., Layton, O., Wasson, L. K., Letendre, J. H., Xiao, F., Ewoldt, J. K., Gkatzis, K., Sommer, P., Gobert, B., Wiest-Daesslé, N., McAfee, Q., Singhal, N., …, & Seidman, C. E. (2025). Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer. Journal of Clinical Investigation, 135(4). https://doi.org/10.1172/jci183353

Vancouver

Kim Y, Kim SW, Saul D, Neyazi M, Schmid M, Wakimoto H, et al. Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer. Journal of Clinical Investigation. 2025;135(4). doi:10.1172/jci183353

BibTeX
@article{Kim2025,
  author = {Kim, Yuri and Kim, Seong Won and Saul, David and Neyazi, Meraj and Schmid, Manuel and Wakimoto, Hiroko and Slaven, Neil and Lee, Joshua H and Layton, Olivia and Wasson, Lauren K and Letendre, Justin H and Xiao, Feng and Ewoldt, Jourdan K and Gkatzis, Konstantinos and Sommer, Peter and Gobert, Bénédicte and Wiest-Daesslé, Nicolas and McAfee, Quentin and Singhal, Nandita and Lun, Mingyue and Gorham, Joshua M and Arany, Zolt and Sharma, Arun and Toepfer, Christopher N and Oudit, Gavin Y and Pu, William T and Dickel, Diane E and Pennacchio, Len A and Visel, Axel and Chen, Christopher S and Seidman, J G and Seidman, Christine E},
  title = {Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {4},
  doi = {10.1172/jci183353}
}
Kostenlos starten →